| TME Profiling |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
07. Juli 2024 |
| Clinical Sciences Trial Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
10. Juli 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Japan Program Clinical Head (IMM) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Biomedical Research |
Innovative Medicines |
Research & Development |
10. September 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Associate Submission Manager |
Hyderabad (Office) |
Indien |
Biomedical Research |
|
Research & Development |
12. August 2024 |
| Director of Global & Swiss Media & Editorial |
Basel (City) |
Schweiz |
Corporate |
CTS |
Communications & Public Affairs |
18. Oktober 2024 |
| Office Manager – Public Affairs (f/m/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
Corporate Affairs |
Innovative Medicines |
Einrichtungen und Verwaltung |
02. September 2024 |
| Director of Commercial Policy Communications and Media Relations, Europe |
Basel (City) |
Schweiz |
Corporate Affairs |
CTS |
Communications & Public Affairs |
24. Oktober 2024 |
| Director, Sustainability & ESG Strategy (Health Equity / Access focus) |
Basel (City) |
Schweiz |
Corporate Affairs |
Corporate |
BD&L & Strategic Planning |
15. Oktober 2024 |
| Comms & Engagement Manager |
Amsterdam |
Niederlande |
Corporate Affairs |
CTS |
Communications & Public Affairs |
16. Oktober 2024 |
| Executive Director, Therapy Area Communications and Patient Advocacy |
Basel (City) |
Schweiz |
Corporate Affairs |
CTS |
Communications & Public Affairs |
16. Oktober 2024 |
| Associate Director, Corporate Event Marketing |
East Hanover (New Jersey) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
22. Oktober 2024 |
| Associate Director, Political Affairs & Insights |
Washington, DC |
USA |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
22. Oktober 2024 |
| EA & Program Coordinator |
Beijing (Beijing) |
China |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
22. Oktober 2024 |
| Government Affairs Manager |
Moscow (City) |
Russische Foed. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
22. Oktober 2024 |
| Manager, Post Production & Video Services |
Hyderabad (Office) |
Indien |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04. Oktober 2024 |
| Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
08. Oktober 2024 |
| Associate Director, Finance and Strategy & Growth Activation Communications |
East Hanover |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
08. Oktober 2024 |
| Patient Engagement Lead |
İstanbul Kavacık |
Türkei |
Corporate Affairs |
CTS |
Communications & Public Affairs |
03. September 2024 |
| Chef, Communications corporatives |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
21. Oktober 2024 |
| Manager, Corporate Communications |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
21. Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Research & Development Quality Specialist |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Quality |
15. Oktober 2024 |
| SSO Finance Specialist |
İstanbul Kavacık |
Türkei |
Development |
Innovative Medicines |
Research & Development |
10. September 2024 |
| RA Manager, Procedural Documents |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
10. September 2024 |
| RA GDD Project Specialist |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Einrichtungen und Verwaltung |
10. September 2024 |
| Director, Global Operational Excellence |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
11. September 2024 |
| Senior Regulatory Affairs Manager |
Vietnam |
Vietnam |
Development |
Innovative Medicines |
Research & Development |
22. Oktober 2024 |
| Head, Clinical Development Strategy & Integration Lead |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
12. September 2024 |
| Manager, Reg&Dev Policy Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
12. September 2024 |
| Associate Director- Clinical Data Standards |
Mumbai (Office) |
Indien |
Development |
Innovative Medicines |
Research & Development |
13. September 2024 |
| Senior Global Risk Management Plan Manager |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Research & Development |
16. September 2024 |
| Principal Biostatistician |
Home Worker |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| Director Quantitative Safety Scientist |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| Global Labelling Manager |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| SSO Site Partnership Manager |
Guangzhou (Guangdong Province) |
China |
Development |
Innovative Medicines |
Research & Development |
17. September 2024 |
| GCP Inspection Project Manager |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Quality |
16. Oktober 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| RA Operational Excellence Junior Associate – MEA |
Dubai |
Vereinigte Arabische Emirate |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Vendor Alliance Lead Associate Director (Remote) |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Sandoz |
Research & Development |
17. Oktober 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Expert Science & Technology II- Analytical Research & Development |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
18. September 2024 |